Skip to content
Vensana

Vensana

  • Our Team
  • Values
  • Our Entrepreneurs

Entrepreneur Type: Legacy

Monteris

Ceterix

Metavention

Zyga

Vytronus

Vesper Medical

Veran

Vertiflex

Ulthera

Topera

SequentMedical

Senseonics

Respicardia

Relievant

PGDx

Nuvaira

Neuwave

Lutonix

Intact

Inari

Fire1

EPIX

Cvingenuity

ClarVista

ChromeCoda

Cartiva

Cameron Health

CardiAQ

17

Novel FDA PMA & de novo 510k approvals

37

U.S. Commercial Product Launches

34

Level I Clinical Trials

23

Strategic Financings

25

Exits by IPO or M&A

VENSANA CAPITAL

CAPITAL PARTNERS FOR HEALTHCARE ENTREPRENEURS℠

Ready to change healthcare together?

Get in Touch

Our Latest

See All News
SpyGlass Ophthalmics Completes $27.5 Million Series B Financing to Advance Novel Treatments for Chronic Ophthalmic Diseases
Relievant Medsystems Announces $70M Financing to Accelerate U.S. Commercialization of Intracept Procedure
Philips to expand its image-guided therapy devices portfolio through acquisition of Intact Vascular
Resources
News LP Access
Contact
info@vensanacap.com 612.217.8680
Engage
Minneapolis
Vensana Capital 3601 W 76th Street Suite 20 Minneapolis, MN 55435
Washington, D.C.
Vensana Capital 101 Church Street Suite D Vienna, VA 22180

© 2019 Vensana Capital Management, LLC | Privacy | Terms & Conditions